In particular, in our model, 5% BC supplementation significantly increased IL-8 and TGF-β expression in the jejunum compared to the control and 2.5% BC groups, but no effect was observed in the large intestine (caecum and colon). The gene discussed is CXCL8; the disease is breast cancer.